Tetragon Partners GP Ltd
CIK: 0001515070Latest portfolio: $474.3M · Q4 2025
Holdings
28
Total Value
$474.3M
New Positions
9
Closed Positions
24
Top Holdings
View All 28 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | PATHUIPATH INC | 17,450,000 | $286.0M | 60.30% | +500K | |
| 2 | KGEIKOLIBRI GLOBAL ENERGY INC | 6,934,504 | $27.3M | 5.75% | -136,064 | |
| 3 | LYFTLYFT INC | 1,000,000 | $19.4M | 4.08% | — | |
| 4 | AUTLAUTOLUS THERAPEUTICS PLC | 9,500,000 | $18.9M | 3.99% | — | |
| 5 | CXMSPRINKLR INC | 2,200,000 | $17.1M | 3.61% | — | |
| 6 | WKWORKIVA INC | 150,000 | $12.9M | 2.73% | — | |
| 7 | ANNXANNEXON INC | 2,032,455 | $10.2M | 2.15% | -80,000 | |
| 8 | PRAXPRAXIS PRECISION MEDICINES I | 22,952 | $6.8M | 1.43% | NEW | |
| 9 | TCE2CELLDEX THERAPEUTICS INC NEW | 243,800 | $6.6M | 1.40% | -59,800 | |
| 10 | ARWRARROWHEAD PHARMACEUTICALS IN | 96,935 | $6.4M | 1.36% | +15K | |
| 11 | PHVSPHARVARIS N V | 194,612 | $5.4M | 1.14% | — | |
| 12 | AXSMAXSOME THERAPEUTICS INC | 26,934 | $4.9M | 1.04% | -19,522 | |
| 13 | DYNDYNE THERAPEUTICS INC | 247,997 | $4.8M | 1.02% | +25K | |
| 14 | MBXMBX BIOSCIENCES INC | 143,327 | $4.5M | 0.95% | -34,513 | |
| 15 | RAPTRAPT THERAPEUTICS INC | 131,770 | $4.5M | 0.94% | NEW | |
| 16 | AGIOAGIOS PHARMACEUTICALS INC | 162,018 | $4.4M | 0.93% | NEW | |
| 17 | IMVTIMMUNOVANT INC | 166,187 | $4.2M | 0.89% | -22,192 | |
| 18 | ALKSALKERMES PLC | 141,172 | $3.9M | 0.83% | +52K | |
| 19 | AM6AMICUS THERAPEUTICS INC | 260,771 | $3.7M | 0.78% | +140K | |
| 20 | AMLXAMYLYX PHARMACEUTICALS INC | 272,828 | $3.3M | 0.69% | +15K | |
| 21 | HRMYHARMONY BIOSCIENCES HLDGS IN | 82,824 | $3.1M | 0.65% | NEW | |
| 22 | NKTRNEKTAR THERAPEUTICS | 69,287 | $2.9M | 0.62% | NEW | |
| 23 | KRYSKRYSTAL BIOTECH INC | 11,814 | $2.9M | 0.61% | +7K | |
| 24 | MPLTMAPLIGHT THERAPEUTICS INC | 164,525 | $2.9M | 0.61% | NEW | |
| 25 | SLNSILENCE THERAPEUTICS PLC | 365,369 | $2.2M | 0.47% | NEW |
Quarterly Changes
New Positions
Closed Positions
- BABA 0.5 06/01/31CLOSED$174.8B
- HYGCLOSED$64.9B
- LARCN 1.75 01/15/27CLOSED$24.6B
- CABO 0 03/15/26CLOSED$20.8B
- PRGSCLOSED$20.6B
- OTLY 9.25 09/14/28CLOSED$18.4B
- AGCN 0.375 01/15/27CLOSED$8.0B
- CELC 2.75 08/01/31CLOSED$7.4B
- TARSCLOSED$7.4B
- SRRKCLOSED$4.4B
Sector Breakdown
Healthcare0.0% ($1.8905102026764642e+71T)
Technology0.0% ($2860041937017116.0T)
Unknown0.0% ($66.2B)
Energy0.0% ($27.3M)
Filing History
| Quarter | Filing Date | Portfolio Value | Holdings |
|---|---|---|---|
| Q4 2025 | Feb 17, 2026 | $474.3M | 31 |
| Q3 2025 | Nov 14, 2025 | $747.6B | 47 |
| Q2 2025 | Aug 14, 2025 | $620.8B | 40 |
| Q1 2025 | May 15, 2025 | $438.2B | 32 |
| Q4 2024 | Feb 14, 2025 | $405.6B | 28 |
| Q3 2024 | Nov 14, 2024 | $354.5B | 26 |
| Q2 2024 | Aug 14, 2024 | $400.9B | 30 |
| Q1 2024 | May 15, 2024 | $441.5B | 32 |
| Q4 2023 | Feb 14, 2024 | $415.3B | 35 |
| Q1 2023 | May 15, 2023 | $747.5B | 57 |
| Q4 2022 | Feb 14, 2023 | $699.0B | 75 |
| Q3 2022 | Nov 14, 2022 | $829.7M | 150 |
| Q2 2022 | Aug 15, 2022 | $1.5B | 199 |
| Q1 2021 | May 17, 2021 | $1.4B | 112 |
| Q4 2020 | Feb 12, 2021 | $1.5B | 50 |
| Q3 2020 | Nov 13, 2020 | $1.1B | 48 |
| Q2 2020 | Aug 14, 2020 | $751.0M | 43 |
| Q1 2020 | May 15, 2020 | $577.9M | 41 |
| Q4 2019 | Feb 12, 2020 | $672.9M | 42 |
| Q2 2019 | Aug 14, 2019 | $688.9M | 58 |
| Q4 2018 | Feb 14, 2019 | $633.9M | 51 |
| Q3 2018 | Nov 14, 2018 | $835.7M | 59 |
| Q2 2018 | Aug 14, 2018 | $742.8M | 55 |
| Q4 2017 | Feb 14, 2018 | $658.5M | 42 |
| Q3 2017 | Nov 14, 2017 | $615.9M | 46 |
| Q2 2017 | Aug 14, 2017 | $672.2M | 45 |
| Q3 2015 | Nov 13, 2015 | $207.7M | 22 |
| Q2 2015 | Aug 13, 2015 | $269.9M | 22 |
| Q1 2015 | May 14, 2015 | $322.1M | 22 |
| Q4 2014 | Feb 13, 2015 | $253.4M | 20 |
| Q3 2014 | Nov 13, 2014 | $275.7M | 22 |
| Q2 2014 | Aug 13, 2014 | $355.4M | 20 |
| Q1 2014 | May 14, 2014 | $181.3M | 15 |
| Q4 2013 | Feb 14, 2014 | $110.6M | 12 |
| Q3 2013 | Nov 14, 2013 | $99.0M | 11 |
| Q2 2013 | Aug 9, 2013 | $140.9M | 14 |
Fund Information
Tetragon Partners GP Ltd is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $474.3M across 28 holdings. The largest position is UIPATH INC (PATH), representing 60.3% of the portfolio. Compared to the previous quarter, the fund opened 9 new positions and closed 24 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.